Tandem Diabetes Care, Inc. (TNDM)
USD 16.43
(-6.96%)
USD 16.43
(-6.96%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 639.02 Million USD | 4.27% |
| 2022 | 612.83 Million USD | 29.83% |
| 2021 | 472.02 Million USD | 34.82% |
| 2020 | 350.11 Million USD | 166.99% |
| 2019 | 131.13 Million USD | 74.8% |
| 2018 | 75.01 Million USD | -39.74% |
| 2017 | 124.49 Million USD | 5.22% |
| 2016 | 118.31 Million USD | 91.92% |
| 2015 | 61.65 Million USD | 18.81% |
| 2014 | 51.89 Million USD | 11.17% |
| 2013 | 46.67 Million USD | -68.0% |
| 2012 | 145.86 Million USD | 71.06% |
| 2011 | 85.27 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 697.98 Million USD | 9.23% |
| 2024 Q2 | 703.62 Million USD | 0.81% |
| 2023 Q4 | 639.02 Million USD | 2.1% |
| 2023 Q3 | 625.9 Million USD | 1.37% |
| 2023 FY | 639.02 Million USD | 4.27% |
| 2023 Q1 | 615.39 Million USD | 0.42% |
| 2023 Q2 | 617.44 Million USD | 0.33% |
| 2022 FY | 612.83 Million USD | 29.83% |
| 2022 Q4 | 612.83 Million USD | -2.06% |
| 2022 Q1 | 577.89 Million USD | 22.43% |
| 2022 Q3 | 625.69 Million USD | 6.59% |
| 2022 Q2 | 586.99 Million USD | 1.57% |
| 2021 FY | 472.02 Million USD | 34.82% |
| 2021 Q2 | 449.16 Million USD | 1.88% |
| 2021 Q1 | 440.85 Million USD | 25.92% |
| 2021 Q4 | 472.02 Million USD | 2.47% |
| 2021 Q3 | 460.62 Million USD | 2.55% |
| 2020 Q4 | 350.11 Million USD | 1.06% |
| 2020 Q3 | 346.44 Million USD | -0.6% |
| 2020 Q1 | 136.15 Million USD | 3.83% |
| 2020 Q2 | 348.53 Million USD | 155.99% |
| 2020 FY | 350.11 Million USD | 166.99% |
| 2019 Q4 | 131.13 Million USD | 4.36% |
| 2019 Q3 | 125.65 Million USD | 14.5% |
| 2019 FY | 131.13 Million USD | 74.8% |
| 2019 Q1 | 93.73 Million USD | 24.95% |
| 2019 Q2 | 109.73 Million USD | 17.07% |
| 2018 Q3 | 66.17 Million USD | -49.86% |
| 2018 Q4 | 75.01 Million USD | 13.36% |
| 2018 FY | 75.01 Million USD | -39.74% |
| 2018 Q1 | 132.85 Million USD | 6.71% |
| 2018 Q2 | 131.98 Million USD | -0.65% |
| 2017 FY | 124.49 Million USD | 5.22% |
| 2017 Q4 | 124.49 Million USD | 7.38% |
| 2017 Q1 | 114.58 Million USD | -3.16% |
| 2017 Q3 | 115.93 Million USD | -0.76% |
| 2017 Q2 | 116.82 Million USD | 1.95% |
| 2016 Q1 | 74.69 Million USD | 21.16% |
| 2016 FY | 118.31 Million USD | 91.92% |
| 2016 Q4 | 118.31 Million USD | 38.97% |
| 2016 Q3 | 85.13 Million USD | 10.4% |
| 2016 Q2 | 77.11 Million USD | 3.24% |
| 2015 FY | 61.65 Million USD | 18.81% |
| 2015 Q4 | 61.65 Million USD | 7.62% |
| 2015 Q3 | 57.28 Million USD | 6.91% |
| 2015 Q2 | 53.58 Million USD | 1.33% |
| 2015 Q1 | 52.87 Million USD | 1.9% |
| 2014 Q1 | 45.12 Million USD | -3.32% |
| 2014 FY | 51.89 Million USD | 11.17% |
| 2014 Q4 | 51.89 Million USD | 5.73% |
| 2014 Q3 | 49.08 Million USD | 5.62% |
| 2014 Q2 | 46.47 Million USD | 2.97% |
| 2013 Q1 | - USD | -100.0% |
| 2013 Q2 | 190.71 Million USD | 0.0% |
| 2013 Q3 | 192.01 Million USD | 0.68% |
| 2013 Q4 | 46.67 Million USD | -75.69% |
| 2013 FY | 46.67 Million USD | -68.0% |
| 2012 FY | 145.86 Million USD | 71.06% |
| 2012 Q4 | 145.86 Million USD | 0.0% |
| 2011 FY | 85.27 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 51.25 Million USD | -1146.783% |
| BrainsWay Ltd. | 15.31 Million USD | -4072.822% |
| Cerus Corporation | 144.3 Million USD | -342.833% |
| Envoy Medical, Inc. | 9.4 Million USD | -6696.703% |
| electroCore, Inc. | 8.94 Million USD | -7043.946% |
| Helius Medical Technologies, Inc. | 5.34 Million USD | -11862.299% |
| IceCure Medical Ltd | 4.24 Million USD | -14946.527% |
| Inogen, Inc. | 121.38 Million USD | -426.459% |
| OrthoPediatrics Corp. | 72.56 Million USD | -780.674% |
| Lucid Diagnostics Inc. | 29.58 Million USD | -2060.258% |
| Monogram Orthopaedics, Inc. | 3.18 Million USD | -19982.886% |
| MaxCyte, Inc. | 36.1 Million USD | -1669.812% |
| NeuroOne Medical Technologies Corporation | 1.84 Million USD | -34481.013% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -150159.711% |
| Orthofix Medical Inc. | 326.58 Million USD | -95.669% |
| PAVmed Inc | 57.13 Million USD | -1018.41% |
| Rapid Micro Biosystems, Inc. | 25.46 Million USD | -2409.626% |
| RxSight, Inc. | 22.18 Million USD | -2780.052% |
| Sight Sciences, Inc. | 46.43 Million USD | -1276.144% |
| SI-BONE, Inc. | 61.05 Million USD | -946.726% |
| TELA Bio, Inc. | 59.16 Million USD | -980.038% |
| Treace Medical Concepts, Inc. | 113.96 Million USD | -460.702% |
| Vivos Therapeutics, Inc. | 10.31 Million USD | -6092.712% |
| Acutus Medical, Inc. | 54.83 Million USD | -1065.277% |
| Talis Biomedical Corporation | 29.22 Million USD | -2086.648% |
| Spectral AI, Inc. | 12.4 Million USD | -5053.02% |
| Nano-X Imaging Ltd. | 23.13 Million USD | -2662.281% |
| CVRx, Inc. | 39.28 Million USD | -1526.765% |
| DIH Holding US, Inc. Warrants | 11.95 Million USD | -5243.886% |
| PetVivo Holdings, Inc. | 2.42 Million USD | -26204.944% |
| Bioventus Inc. | 589.79 Million USD | -8.348% |
| Venus Concept Inc. | 107.1 Million USD | -496.646% |
| TriSalus Life Sciences, Inc. | 51.66 Million USD | -1136.912% |
| LivaNova PLC | 1.15 Billion USD | 44.526% |
| 908 Devices Inc. | 37.49 Million USD | -1604.524% |
| Alphatec Holdings, Inc. | 703.48 Million USD | 9.163% |
| Nemaura Medical Inc. | 26.37 Million USD | -2322.624% |
| NeuroPace, Inc. | 86.99 Million USD | -634.538% |
| LENSAR, Inc. | 22.4 Million USD | -2751.649% |
| Apyx Medical Corporation | 52.31 Million USD | -1121.427% |
| Cutera, Inc. | 518.12 Million USD | -23.335% |
| STRATA Skin Sciences, Inc. | 29.32 Million USD | -2078.894% |
| BioSig Technologies, Inc. | 4.68 Million USD | -13539.829% |
| Anika Therapeutics, Inc. | 58.36 Million USD | -994.841% |
| ClearPoint Neuro, Inc. | 21.48 Million USD | -2873.874% |
| Integra LifeSciences Holdings Corporation | 2.19 Billion USD | 70.875% |
| Axonics, Inc. | 82.35 Million USD | -675.903% |
| Outset Medical, Inc. | 190.91 Million USD | -234.718% |
| IRIDEX Corporation | 24.91 Million USD | -2464.927% |
| PROCEPT BioRobotics Corporation | 123.96 Million USD | -415.489% |
| IRadimed Corporation | 20.73 Million USD | -2981.732% |
| Tivic Health Systems, Inc. | 1.67 Million USD | -38073.596% |
| INVO Bioscience, Inc. | 19.99 Million USD | -3095.935% |
| Telesis Bio, Inc. | 40.87 Million USD | -1463.443% |
| Viemed Healthcare, Inc. | 40.79 Million USD | -1466.615% |
| Varex Imaging Corporation | 668.6 Million USD | 4.423% |
| Quipt Home Medical Corp. | 136.29 Million USD | -368.862% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -17789.866% |
| Pulmonx Corporation | 60.63 Million USD | -953.872% |
| Dynatronics Corporation | 11.78 Million USD | -5324.616% |
| Modular Medical, Inc. | 2.27 Million USD | -28026.144% |
| ReShape Lifesciences Inc. | 4.06 Million USD | -15624.065% |
| Semler Scientific, Inc. | 6.27 Million USD | -10091.802% |
| InMode Ltd. | 75.91 Million USD | -741.776% |
| Bruker Corporation | 2.83 Billion USD | 77.472% |
| Cytosorbents Corporation | 29.98 Million USD | -2031.119% |
| DexCom, Inc. | 4.19 Billion USD | 84.77% |
| Align Technology, Inc. | 2.45 Billion USD | 73.953% |
| Viveve Medical, Inc. | 10.84 Million USD | -5791.269% |
| ZimVie Inc. | 795.85 Million USD | 19.705% |
| Movano Inc. | 5.97 Million USD | -10600.368% |
| Cytek Biosciences, Inc. | 104.6 Million USD | -510.894% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -150159.711% |
| DIH Holdings US, Inc. Class A Common Stock | 11.95 Million USD | -5243.886% |
| Profound Medical Corp. | 12.66 Million USD | -4945.262% |
| Insulet Corporation | 1.85 Billion USD | 65.56% |
| enVVeno Medical Corporation | 2.43 Million USD | -26143.368% |
| Surmodics, Inc. | 65.82 Million USD | -870.825% |
| iCAD, Inc. | 8 Million USD | -7886.828% |
| Nuwellis, Inc. | 6.78 Million USD | -9325.162% |
| Biotricity, Inc. | 35.91 Million USD | -1679.053% |
| iRhythm Technologies, Inc. | 223.04 Million USD | -186.498% |
| Aethlon Medical, Inc. | 2.47 Million USD | -25670.814% |
| InspireMD, Inc. | 8.14 Million USD | -7748.515% |
| PAVmed Inc. | 57.13 Million USD | -1018.41% |
| BIOLASE, Inc. | 35.34 Million USD | -1707.814% |
| Beyond Air, Inc. | 29.77 Million USD | -2046.183% |
| FONAR Corporation | 57.45 Million USD | -1012.17% |
| AxoGen, Inc. | 101.16 Million USD | -531.686% |
| Vivani Medical, Inc. | 25.03 Million USD | -2452.429% |
| Tactile Systems Technology, Inc. | 87.79 Million USD | -627.853% |
| Inari Medical, Inc. | 209.32 Million USD | -205.279% |
| UFP Technologies, Inc. | 118.04 Million USD | -441.341% |
| QT Imaging Holdings, Inc. | 12.69 Million USD | -4935.47% |
| Heart Test Laboratories, Inc. | 2.18 Million USD | -29135.177% |
| Tenon Medical, Inc. | 5.56 Million USD | -11378.822% |
| Autonomix Medical, Inc. Common Stock | 1.77 Million USD | -35820.517% |
| Co-Diagnostics, Inc. | 17.63 Million USD | -3523.805% |
| AdaptHealth Corp. | 3.15 Billion USD | 79.734% |
| Sintx Technologies, Inc. | 6.59 Million USD | -9592.492% |
| NanoVibronix, Inc. | 2.68 Million USD | -23690.99% |
| Quanterix Corporation | 78.08 Million USD | -718.383% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -17789.866% |
| Sensus Healthcare, Inc. | 4.88 Million USD | -12981.392% |
| Pacific Biosciences of California, Inc. | 1.04 Billion USD | 38.832% |
| TransMedics Group, Inc. | 568.84 Million USD | -12.337% |
| ReWalk Robotics Ltd. | 16.68 Million USD | -3730.632% |
| NeuroMetrix, Inc. | 1.33 Million USD | -47834.476% |
| Hyperfine, Inc. | 9.8 Million USD | -6420.673% |
| Establishment Labs Holdings Inc. | 250.24 Million USD | -155.359% |
| Biomerica, Inc. | 2.66 Million USD | -23896.47% |
| Bone Biologics Corporation | 831.4 Thousand USD | -76761.254% |
| AVITA Medical, Inc. | 19.86 Million USD | -3116.778% |
| Bluejay Diagnostics, Inc. | 1.97 Million USD | -32277.337% |
| Silk Road Medical, Inc | 114.15 Million USD | -459.773% |